Literature DB >> 2524527

Retention of ligand binding activity by the extracellular domain of the IL-1 receptor.

S K Dower1, J M Wignall, K Schooley, C J McMahan, J L Jackson, K S Prickett, S Lupton, D Cosman, J E Sims.   

Abstract

The IL-1R on murine T cells is an 80-kDa cell surface glycoprotein which binds both IL-1 alpha and IL-1 beta. We have recently isolated a cDNA clone encoding this molecule. From the primary sequence mature receptor is predicted to be a 557 residue integral membrane protein with a 319 residue carbohydrate-rich extracellular region. We have constructed a cDNA clone encoding this region of the protein (residues 1 to 316). Expression of this cDNA in HeLa cells leads to secretion of a soluble IL-1 alpha binding protein into the culture medium. Quantitative binding experiments with the truncated receptor show that it possesses IL-1 binding properties which are indistinguishable from those of full length IL-1R. Gel filtration chromatography experiments show that a complex can be formed between a single truncated receptor molecule and a single IL-1 alpha molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524527

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Cloning the interleukin 1 receptor from human T cells.

Authors:  J E Sims; R B Acres; C E Grubin; C J McMahan; J M Wignall; C J March; S K Dower
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.

Authors:  J A Symons; P R Young; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

3.  Interleukin-1 administration to C3H/HeJ mice after but not prior to infection increases resistance to Salmonella typhimurium.

Authors:  P J Morrissey; K Charrier
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Immunomodulatory activity of recombinant IL-1 receptor (IL-1-R) on models of experimental rheumatoid arthritis.

Authors:  H U Schorlemmer; E J Kanzy; K D Langner; R Kurrle
Journal:  Agents Actions       Date:  1993

5.  Immunoregulation of SLE-like disease by the IL-1 receptor: disease modifying activity on BDF1 hybrid mice and MRL autoimmune mice.

Authors:  H U Schorlemmer; E J Kanzy; K D Langner; R Kurrle
Journal:  Agents Actions       Date:  1993

6.  Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice.

Authors:  H W Rogers; K C Sheehan; L M Brunt; S K Dower; E R Unanue; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

7.  Expression of the IL-1 receptor discriminates Th2 from Th1 cloned CD4+ T cells specific for Plasmodium chabaudi.

Authors:  A W Taylor-Robinson; R S Phillips
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

8.  Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.

Authors:  R M Burch; L C Mahan
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

9.  A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.

Authors:  C J McMahan; J L Slack; B Mosley; D Cosman; S D Lupton; L L Brunton; C E Grubin; J M Wignall; N A Jenkins; C I Brannan
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.